- Patricia H. Fabel, PharmD, BCPS; Executive Director, Kennedy Pharmacy Innovation Center and Clinical Associate Professor
- Kathy Quarles Moore, BSPharm, RPh, CDM; Lab Director, Community and Compounding Labs
- Cynthia Phillips, PharmD; Clinical Associate Professor / Clinical Pharmacy and Outcomes Sciences
- Provide comprehensive instruction on current standards of care for patients with diabetes.
- Increase pharmacists’ ability to apply pharmacotherapeutic information and serve as the drug therapy expert on the diabetes health care team.
- Refresh pharmacists’ knowledge of the pathophysiology of diabetes and the acute and long?term complications of the disease.
- Familiarize pharmacists with important concepts in nutrition, exercise, and weight control that contribute to optimal diabetes care.
- Provide training on the use of diabetes-related devices and physical assessments involved with optimal diabetes care.
- Describe business opportunities and roles for pharmacists in improving health outcomes for patients with diabetes.
- This ACPE activity does not provide a certification in this topic but rather advanced professional training which upon successful completion the learner will be able to download a certificate of achievement.
- Welcome, Introductions and Acknowledgements
- Comprehensive Diabetes Care
- Treating Type 2 Diabetes
- Insulin Therapy in Type 1 and Type 2 Diabetes
- Lunch and Networking
- Nutrition and Lifestyle Counseling for Patients
- Hands-On Skills Practice
- Next Steps and Resources
- Post-Seminar Final Instructions
- Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 15 contact hours of CPE credit (1.5 CEUs). ACPE UAN: 0202-0000-18-121-H01-P
- Successful completion of the live seminar component involves attending the full live seminar, successfully demonstrate competency in the utilization and/or evaluation of these devices, and completing the online assessment and evaluation. Successful completion of this component will result in 8 contact hours of CPE credit (0.8 CEU). ACPE UAN: 0202-0000-18-122-L01-P
- Jennifer D. Smith, PharmD, CPP, BC-ADM, CDE, (Chair) Clinical Pharmacy Specialist in an Outpatient Center, U.S. Department of Veterans Affairs; Upstate South Carolina
- Stuart T. Haines, PharmD, FCCP, FASHP, FAPhA, Professor and Vice Chair for Education in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, and a Clinical Associate Professor in Medicine at the UM School of Medicine, Baltimore, Maryland
- Tommy Johnson, PharmD, BC-ADM, CDE, FAADE, Assistant Dean of Operations, South University College of Pharmacy-Columbia, Columbia, South Carolina
- Natalie Kunze, PharmD, CDE, Clinical Care Pharmacist, Kroger, Cincinnati, Ohio
- Staci-Marie Norman, PharmD, CDE, Clinical Coordinator and Manager, Martin’s Pharmacy, South Bend, Indiana
- Jennifer Trujillo, PharmD, BCPS, CDE, BC-ADM, Associate Professor, Department of Clinical Pharmacy, University of Colorado School of Pharmacy, Aurora, Colorado
- Helen Ali-Sairany, PharmD, Associate Director, Content Development, Education
- Kelly French, Director, Advanced Training
- Misty Knack, Associate Director, Advanced Training
- Stuart T. Haines, PharmD, FCCP, FASHP, FAPhA, serves as an educational consultant for Sanofi for which he has received an honorarium.
- Staci-Marie Norman, PharmD, CDE, declares she serves as a speaker for Lilly and has received an honorarium. She also declares her spouse is a sales representative for Takeda.
- Jennifer Trujillo, PharmD, BCPS, CDE, BC-ADM, declares her spouse serves as a consultant for Pfizer, Janssen, and Boehringer Ingelheim.
- All other individuals involved in the development of this material declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete APhA staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.
- Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
- The material presented here does not necessarily reflect the views of the American Pharmacists Association. Every attempt has been made to ensure the accuracy of the information contained herein at the time of writing; however, owing to the nature of pharmacy practice, standards and recommendations change regularly. Pharmacists are advised to verify all information and data before treating patients or employing the practices described in this educational activity.
Date: Nov 1, 2020 12:00 PM - 08:00 PM
- Practice Based
- Explain important concepts in glucose homeostasis.
- Describe the pathophysiology and clinical manifestations of type 1 diabetes and type 2 diabetes.
- List laboratory test values and ranges that represent important diagnostic criteria or treatment goals for patients with diabetes.
- Describe the evidence base to support treatment goals for patients with diabetes.
- Discuss findings from trials investigating the relationship between A1C and atherosclerotic cardiovascular disease.
- List blood glucose treatment targets for various subgroups of patients with diabetes.
- Describe the role and application of A1C testing and self-monitoring of blood glucose in type 1 and type 2 diabetes.
- Explain strategies for managing hypoglycemia.
- Apply concepts and recommendations from current dietary, physical activity, and weight management guidelines to the specific needs of patients with diabetes.
- Discuss basic concepts of carbohydrate counting and meal planning for patients with diabetes.
- Summarize current recommendations for smoking cessation.
- Differentiate among the many oral, injectable, and inhalational agents available for the treatment of diabetes and categorize antidiabetic agents according to their primary mechanism of action, principal adverse effects, and rational role in therapy.
- Explain currently accepted approaches to managing type 1 and type 2 diabetes as well as the appropriate clinical use of available oral, injectable, and inhalational antidiabetic agents.
- Specify treatment goals and strategies for controlling cardiovascular risk factors in patients with diabetes.
- Identify screening and treatment recommendations for comprehensive diabetes care, including recommendations addressing nephropathy, retinopathy, foot problems, and immunizations.
- Describe outcomes associated with pharmacists’ patient care services for patients who have diabetes.
- List elements of diabetes self-management education.
- Identify barriers to diabetes self-management and propose strategies to address those barriers.
- Apply elements of motivational interviewing, goal setting, problem solving, and cultural sensitivity to interactions with patients with diabetes.
- Explain how pharmacists can obtain recognized diabetes care credentials and establish a formal diabetes self-management education program.
- Evaluate the overall health status of patients with diabetes in terms of recommended monitoring and interventions, and formulate strategies for closing gaps in care.
- Propose modifications to a patient’s drug therapy regimen rooted in evidence-based algorithms for diabetes management.
- Recommend dietary interventions to support optimal glycemic control and weight loss (when indicated) in patients with diabetes.
- Analyze and interpret a patient’s self-monitoring of blood glucose results and use the results to identify needed changes in the diabetes management plan.
- Demonstrate proper technique for measuring blood pressure, administering injections, obtaining fingerstick samples for blood glucose monitoring, operating blood glucose meters, and performing monofilament foot testing.
- Integrate the varied aspects of comprehensive diabetes care into efficient, sensitive, respectful pharmacist-patient interactions that support optimal patient self-management.
- Describe ways in which pharmacists can keep abreast of new developments and take advantage of professional opportunities in diabetes care.
Cynthia Phillips, PharmD, CDE
Kathy Quarles-Moore, B.S.Pharm, RPh, CDM
Patricia Fabel, PharmD, BCPS